Application Nr Approved Date Route Status External Links
NDA021877 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Arranon Is Indicated For The Treatment Of T-Cell Acute Lymphoblastic Leukemia (T-All) And T-Cell Lymphoblastic Lymphoma (T-Lbl) In Adult And Pediatric Patients Age 1 Year And Older Whose Disease Has Not Responded To Or Has Relapsed Following Treatment With At Least 2 Chemotherapy Regimens. Arranon Is A Nucleoside Metabolic Inhibitor Indicated For The Treatment Of Patients With T-Cell Acute Lymphoblastic Leukemia (T-All) And T-Cell Lymphoblastic Lymphoma (T-Lbl) In Adult And Pediatric Patients Age 1 Year And Older Whose Disease Has Not Responded To Or Has Relapsed Following Treatment With At Least Two Chemotherapy Regimens. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Nelarabine NELARABINE ZINC3823492

Comments